Topics

MorphoSys AG Company Profile

20:04 EDT 23rd October 2019 | BioPortfolio

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.The Company, founded in 1992, possesses the unique HuCAL technology (the Human Combinatorial Antibody Library). This library comprises more than ten billion different, fully human antibodies. HuCAL is a very powerful technology, which allows rapid and automated production of high-affinity antibodies. The most important feature of the library is its capability of optimizing fully human antibodies to meet predefined specifications.
Presently, MorphoSys prosecutes its business in two operating segments. One segment, the Therapeutic Antibodies unit, develops drug candidates for commercial partners as well as MorphoSys's own proprietary product pipeline. In this regard, the Company has been successful in establishing a number of partnerships with renowned biotechnology and pharmaceutical companies and also generated several proprietary therapeutic antibody candidates for out-licensing to partners. MorphoSys's second operating segment, the Research Antibodies unit, delivers high-quality antibodies to the research market, under the brand AbD – Serotec. The recent acquisitions of Serotec and Biogenesis, which bring strong catalog and industrial antibody production business, have signficantly strengthened and broadened MorphoSys's position in the research antibody market. The resulting combined activities of MorphoSys’s AbD unit serve all segments of the research and diagnostics markets.

Location

Lena-Christ-Strasse 48
Martinsried
Planegg
82152
Germany

Contact

Phone: 49 (0)89 / 899 27-0
Fax: 49 (0)89 / 899 27-222
Email: investors@morphosys.com


News Articles [400 Associated News Articles listed on BioPortfolio]

Morphosys: Verbesserte Perspektiven

Die Analysten von JP Morgan stehen den Aktien von Morphosys weiter positiv gegenüber. Sie bestätigen in einer aktuellen Studie das Rating "overweight" für die Papiere von Morphosys. Das Kursziel f...

Morphosys: Hohes Übernahmepotenzial?

Der Titel des Biotech-Unternehmens Morphosys kämpft derzeit wieder mit der Kursmarke von 100 Euro und in den vergangenen zwei Wochen können sich Morphosys-Aktionäre über einen Kursgewinn in Höhe ...

Morphosys: Ist der Konsens in Gefahr?

Bei Morphosys dürfte es bald die Zahlen für 2018 geben. Im Vorfeld bestätigen die Analysten der Deutschen Bank die Kaufempfehlung für die Aktien von Morphosys. Das Kursziel sehen die Experten weit...

Morphosys: Auf einmal ist alles anders

Die Aktie des Biotech-Unternehmens Morphosys kämpft derzeit wieder mit der Kursmarke von 100 Euro. In den vergangenen zwei Wochen können sich Morphosys-Aktionäre über einen Kursgewinn in Höhe von...

MorphoSys: Kursziel 110 Euro

Kulmbach (www.aktiencheck.de) - MorphoSys-Aktienanalyse von "Der Aktionär": Thomas Bergmann von "Der Aktionär" nimmt die Aktie des Biotech-Unternehmens MorphoSys AG (ISIN: DE0006632003, WKN: 663200....

DGAP-Stimmrechte: MorphoSys AG (deutsch)

MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: MorphoSys AG MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG m...

MorphoSys: Die Rally geht weiter

Kulmbach (www.aktiencheck.de) - MorphoSys-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie des Biotech-Konzerns MorphoSys AG (ISIN: DE0006632003, ....

MorphoSys: Starke Aussichten - Für Neueinstieg ist es noch nicht zu spät

Kulmbach (www.aktiencheck.de) - MorphoSys-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie des Biotech-Konzerns MorphoSys AG (ISIN: DE0006632003, ....

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

MorphoSys GmbH

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

MorphoSys AG,

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 bill...

More Information about "MorphoSys AG" on BioPortfolio

We have published hundreds of MorphoSys AG news stories on BioPortfolio along with dozens of MorphoSys AG Clinical Trials and PubMed Articles about MorphoSys AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MorphoSys AG Companies in our database. You can also find out about relevant MorphoSys AG Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record